WO2026028111 - SOLID ORAL COMPOSITION OF TELMISARTAN SODIUM AND PREPARATION THEREOF
National phase entry is expected:
Publication Number
WO/2026/028111
Publication Date
05.02.2026
International Application No.
PCT/IB2025/057720
International Filing Date
30.07.2025
Title **
[English]
SOLID ORAL COMPOSITION OF TELMISARTAN SODIUM AND PREPARATION THEREOF
[French]
COMPOSITION ORALE SOLIDE DE TELMISARTAN SODIQUE ET SA PRÉPARATION
Applicants **
MOREPEN LABORATORIES LIMITED
Inventors
CHATURVEDI, Kiran
SINGH, Bhuvnesh Kumar
SURI, Sanjay
Priority Data
202411058309
01.08.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1956 | |
| EPO | Filing, Examination, Granting | 11558 | |
| Japan | Filing, Examination, Granting | 1998 | |
| South Korea | Filing, Examination, Granting | 1804 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
23,256
Contact Us
Abstract[English]
The present invention relates to a solid oral pharmaceutical composition of telmisartan sodium as an active ingredient and its preparation thereof. More specifically, the present invention provides a stable pharmaceutical composition of telmisartan sodium having minimal weight and reduced size.[French]
La présente invention concerne une composition pharmaceutique orale solide de telmisartan sodique en tant que principe actif et sa préparation. Plus spécifiquement, la présente invention concerne une composition pharmaceutique stable de telmisartan sodique ayant un poids minimal et une taille réduite.